Bellone J, Farello G, Bartolotta E, Aimaretti G, Bellone S, Mucci M, De Matteis F, Ghigo E
Division of Endocrinology, University of Turin, Italy.
Clin Endocrinol (Oxf). 1997 Jul;47(1):61-4. doi: 10.1046/j.1365-2265.1997.2161034.x.
It is widely accepted that arginine is a potent GH secretagogue in man, probably acting via inhibition of hypothalamic somatostatin release. Although many other amino acids are known to stimulate GH secretion, their effects and mechanisms of action have not been extensively studied in humans. The aim of the present study was to clarify the effect, if any, of methionine (MET) on GH secretion in children with normal short stature (normal height velocity and IGF-1 > 100 micrograms/l).
We studied the effect of MET (0.2 g/kg intravenously (i.v.) over 30 min) on both basal and GHRH (1 microgram/kg i.v. at 0 min)-induced GH secretion (group A) comparing its effect with that of arginine (ARG) at low and classical doses 0.2 and 0.5 g/kg i.v. over 30 min) (groups B and C). The effect of the combined administration of MET and ARG (0.5 g/kg i.v. over e0 min) (group D) on GH secretion was also studied.
Thirty-four children (20 male and 14 female, age 12.8-14.0 years), divided into four groups.
Serum Gh was measured in duplicate by immunoradiometric assay.
In group A, MET increased basal Gh levels (peak, mean +/- SEM 14.6 +/- 2.6 vs 2.6 +/- 0.6 mU/l; P < 0.01) and potentiated the GH response to 1 microgram/kg i.v. GHRH (78.0 +/- 17.6 vs 41.6 +/0 9.8 mU/I; P < 0.02). In group B, ARG (0.2 g/kg) increased basal GH levels (16.2 +/- 5.2 vs 2.4 +/- 0.6 mU/I; P < 0.03) and potentiated the GH response to GHRH (119.6 +/- 20.4 vs 48.8 +/- 14.2 mU/I; P < 0.01). In group C, ARG (0.5 g/kg) induced a clear GH rise (28.0 +/- 3.8 vs 2.0 +/- 0.6 mU/I; P < 0.001) and potentiated the GH response to GHRH (93.4 +/- 10.0 vs 34.2 +/- 4.6 mU/I; P < 0.001). The GH responses to MET and ARG alone in groups A and B were similar and lower than that to ARG in group C. The GH responses to MET or ARG combined with GHRH in groups A, B and C were similar. In group D MET failed to modify the GH response to 0.5 g/kg i.v. ARG (10.8 +/- 6.4 vs 9.6 +/- 6.0 mU/I).
Methionine potentiates both basal and GHRH-induced Gh secretion in children as effectively as arginine. As methionine has no interaction with arginine, our data suggest that these amino acids act via a common mechanism.
人们普遍认为精氨酸是人体中一种有效的生长激素促分泌素,可能通过抑制下丘脑生长抑素的释放发挥作用。虽然已知许多其他氨基酸可刺激生长激素分泌,但它们在人体中的作用及作用机制尚未得到广泛研究。本研究的目的是明确蛋氨酸(MET)对正常身材矮小儿童(身高增长速度正常且胰岛素样生长因子-1>100微克/升)生长激素分泌的影响(若有)。
我们研究了MET(0.2克/千克静脉注射,30分钟内)对基础及生长激素释放激素(GHRH,0分钟时1微克/千克静脉注射)诱导的生长激素分泌的影响(A组),并将其与低剂量和经典剂量(0.2克/千克和0.5克/千克静脉注射,30分钟内)的精氨酸(ARG)的作用进行比较(B组和C组)。还研究了MET与ARG联合给药(0.5克/千克静脉注射,30分钟内)(D组)对生长激素分泌的影响。
34名儿童(20名男性和14名女性,年龄12.8 - 14.0岁),分为四组。
采用免疫放射分析法对血清生长激素进行双份测定。
在A组中,MET提高了基础生长激素水平(峰值,平均值±标准误14.6±2.6对2.6±0.6毫单位/升;P<0.01),并增强了对1微克/千克静脉注射GHRH的生长激素反应(78.0±17.6对41.6±9.8毫单位/升;P<0.02)。在B组中,ARG(0.2克/千克)提高了基础生长激素水平(16.2±5.2对2.4±0.6毫单位/升;P<0.03),并增强了对GHRH的生长激素反应(119.6±20.4对48.8±14.2毫单位/升;P<0.01)。在C组中,ARG(0.5克/千克)引起明显的生长激素升高(28.0±3.8对2.0±0.6毫单位/升;P<0.001),并增强了对GHRH的生长激素反应(93.4±10.0对34.2±4.6毫单位/升;P<0.001)。A组和B组中单独使用MET和ARG时的生长激素反应相似,且低于C组中ARG的反应。A组、B组和C组中MET或ARG与GHRH联合使用时生长激素反应相似。在D组中,MET未能改变对0.5克/千克静脉注射ARG的生长激素反应(10.8±6.4对9.6±6.0毫单位/升)。
蛋氨酸在增强儿童基础及生长激素释放激素诱导的生长激素分泌方面与精氨酸同样有效。由于蛋氨酸与精氨酸无相互作用,我们的数据表明这些氨基酸通过共同机制发挥作用。